富于血小板的血与面部关节综合征中的皮质类固醇:一个受控的,随机的,双盲的研究
Marion Geoffroy1, Myriam Beissat2, L Kanagaratnam3
1Rheumatology Department, University Hospital Center of Reims, 45, rue Cognacq-Jay, 51092 Reims, France.
Joint bone spine
|November 3, 2025
概括
富血小板血 (PRP) 注射并没有证明优于皮质类固醇注射来缓解面关节综合征疼痛. 需要进一步的研究来支持PRP在这种情况下的使用.
科学领域:
- 整形外科 整形外科 整形外科
- 再生医学是一种再生医学.
- 疼痛管理 疼痛管理
背景情况:
- 面关节综合征是慢性腰部疼痛的常见原因之一.
- 目前的治疗方法包括皮质类固醇注射,但它们的疗效可能有限.
- 富血小板血 (PRP) 正在作为一种替代性再生疗法的研究中.
研究的目的:
- 为了比较富血小板血 (PRP) 注射与皮质类固醇注射 (CTC) 对面关节综合征的疗效.
- 评估PRP和CTC治疗之间的疼痛减轻,功能改善和患者耐受性.
- 在最初的透管理后评估医疗保健利用率.
主要方法:
- 一项前性,双盲,随机对照试验与76名患者进行.
- 患者在放射学指导下接受了PRP或CTC在面部关节的关节内注射.
- 主要结局是6个月后数值评分表 (NRS) 疼痛得分减少了50%.
主要成果:
- 在3,6或12个月后,在PRP和CTC组之间没有观察到疼痛减轻的统计学上显著差异.
- 在3个月后,在PRP组中,通过奥斯韦斯特里残疾指数 (ODI) 测量的一种统计学上显著的功能改善.
- 患者的满意度和耐受性在各组之间是相似的,报告的短暂不良反应很少.
结论:
- 在6个月后,PRP注射对面部关节综合征的CTC注射没有表现出优势.
- 研究结果目前不支持PRP在面关节综合征的常规使用.
- 进一步的研究可能是有必要的,以探索特定的患者亚组或优化PRP治疗方案.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
423
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
423
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K


